eClinical Solutions Market Will Grow at a Steady Rate of 13.6% from 2014 to 2025: Grand View Research, Inc.


The global eClinical solutions market size is expected to reach USD 12.05 million by 2025, according to a new report by Grand View Research, Inc., progressing at a CAGR of 13.6% during the forecast period. Increasing research and development activities by biopharma and pharma companies, rising application of software solutions in clinical trials, and expanding customer base are anticipated to fuel the demand for eClinical solutions.

The eClinical solutions market is estimated to witness phenomenal growth over the forecast period. Technological advancements in the field of clinical trials such as electronic data capture and prevalence of Wi-Fi connectivity are projected to drive the market in coming years. As the demand for tracking and analyzing clinical data increases, the need for effective clinical solutions rises. Unmet needs to manage efficient clinical development process are poised to boost the growth of the market over the forecast period.




Moreover, digital transformation in the field of clinical trials and shifting preference towards data centric approach are providing a tremendous push to the market. Demand for integrated clinical IT solutions is increasing due to massive volume of data generated during clinical development processes. eClinical solutions offer single source of information that helps in optimizing the cost by eliminating redundant data entry and reducing on-site verification and source data erification rate. Rising awareness regarding these benefits is propelling the market.

Adoption of eClinical workflows in trials offer enormous potential in clinical development processes. These solutions can facilitate decision making in each stage of development. It also helps in reducing cost & time between development phase by utilizing seamless designs & identifying failing compounds. In addition, it offers rapid access to data & patient safety information, which is helpful in making quick decisions.

Browse full research report on eClinical Solutions Market: www.grandviewresearch.com/industry-analysis/eclinical-solutions-market                            
Further key findings from the study suggest:    
                 
  • CTMS dominated the product segment in 2016 owing to associated benefits such as centralized end-to-end management of clinical trial activities, elimination of reliance on manual processes, real-time status tracking, and maintenance of multiple databases, which cumulatively improve the overall efficiency of clinical trials
  • On-premise eClinical solutions are most commonly preferred solutions. The preference for these services is mainly due to complete access to information and have full control within the premise
  • Key market players are engaged in various strategies such as mergers & acquisitions and new product development to gain market penetration
  • New product development and strategic alliances including partnership agreements, promotional activities, and acquisitions are instrumental in keeping market rivalry high
  • For instance, in February 2016, Oracle Health Sciences entered into an agreement with Bayer Healthcare to provide its clinical e-monitoring solutions, Oracle Siebel Clinical Trial Management System, to the latter
Browse more reports of this category by Grand View Research: www.grandviewresearch.com/industry/healthcare-it                                                                                                                                                   
Grand View Research has segmented the global eClinical solutions market report on the basis of end-user application and region:

eClinical Solutions Product Outlook (Revenue, USD Million, 2014 - 2025)
  • Electronic Clinical Outcome Assessment (eCOA)
  • Electronic Data Capture (EDC) and Clinical Data Management Systems (CDMS) 
  • Clinical Analytics Platforms
  • Clinical Data Integration Platforms
  • Safety Solutions
  • Clinical Trial Management Systems (CTMS)
  • Randomization and Trial Supply Management (RTSM) 
  • Electronic Trial Master File (eTMF)
eClinical Solutions Delivery Mode Outlook (Revenue, USD Million, 2014 - 2025)
  • Web-hosted (On-demand)
  • Licensed Enterprise (On-premise)
  • Cloud-based
eClinical Solutions Clinical Trial Outlook (Revenue, USD Million, 2014 - 2025)
  • Phase I
  • Phase II
  • Phase III
  • Phase IV
eClinical Solutions End-use Outlook (Revenue, USD Million, 2014 - 2025)
  • Hospitals
  • CROs
  • Academic Institutes
  • Pharmaceutical Biopharmaceutical Companies
  • Medical Device Manufactures
eClinical Solutions, Regional Outlook (Revenue, USD Million, 2014 - 2025)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Netherlands
    • Sweden
    • Denmark
  • Asia Pacific
    • Japan
    • China
    • India
    • Korea
    • Australia
    • New Zealand
    • Taiwan
    • Hong Kong
    • Singapore
    • Thailand
    • Vietnam
  • Latin America
    • Brazil
    • Argentina
    • Chile
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • U.A.E
    • Egypt
    • Qatar 
Access Press Release By Grand View Research: www.grandviewresearch.com/press-release/global-eclinical-solutions-market                                                                                                                                                    

About Grand View Research:

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more information: www.grandviewresearch.com

Comments

Popular posts from this blog

The global vein illuminator market is expected to reach USD 358.5 million by 2024, according to a new report published by Grand View Research, Inc. The vein illuminator market is anticipated to witness a lucrative growth during the period 2016 to 2024. The factors contributing towards the growth of the market are the growing aging population and the efforts channelized towards improving patient satisfaction. Additionally, factors, such as the demand for technologically advanced medical equipment and the rising research and practical applications are expected to be opportunistic for the industry growth. However, the prevalence of traditional methods owing to the high costs of the vein illuminator devices is likely to hinder the growth of the market in the near future. The vein illuminator market is segmented on the basis of technology, application, end-user, and region. Based on technology, the market is further categorized into transillumination, infrared technology, and ultrasound. The near-infrared illumination technology is estimated to be the largest shareholder due to its ability to penetrate deep into the tissue, which makes it possible to visualize the vessels clearly. On the basis of application, the market is segmented into intravenous access and blood draw. The end-user segment comprises hospitals, rehabilitation facilities, blood donation camps, and academic institutions. The market for hospitals is expected to grow rapidly during the forecast period due to a surge in the demand for technologically advanced medical equipment. The market is also categorized into North America, Europe, Asia Pacific, MEA, and Latin America. Browse full research report on global Vein Illuminator Market: http://www.grandviewresearch.com/industry-analysis/vein-illuminator-market Further key findings from the study suggest: • In terms of market share, the North America vein illuminator market is expected to hold majority of the share in 2016. Factors resulting in the growth of this industry are the steady preference for highly-advanced medical devices by hospitals as well as the presence of several medical device manufacturing companies in the region. • The infrared illumination technology is estimated to lead the industry due to its deep penetration capability into thick tissues tohighlight the presence of vessels with increased clarity. Based on application, the segment for intravenous access is estimated to be the largest shareholder, followed by the blood draw segment. • The vein illuminator industry comprises several local as well as global players. Some prominent players in this industry include Accuvein, Inc., Christie Medical Holdings, Inc., Infrared Imaging Systems, Inc., Translite, LLC, and Venoscope, LLC,among others. In order to hold a major share in the industry, the companies are adopting both organic as well as inorganic strategies. The major strategies adopted by the companies are new product development, mergers, collaborations, partnerships, geographical expansions, and acquisitions. • The companies are also focusing on research and development activities in order to enhance their product portfolio. For instance, in September 2015, Accuvein, Inc., declared its 26th patent, which was issued by the United States Patent and Trademark office for their vein visualization system. Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/medical-devices Grand View Research has segmented the vein illuminator market on the basis of technology, application, and end-user application: Vein Illuminator Technology Outlook (Revenue, USD Million, 2013 - 2024) • Transillumination • Infrared technology • Others Vein Illuminator Application Outlook (Revenue, USD Million, 2013 - 2024) • Intravenous access • Blood draw • Others Vein Illuminator End-user Outlook (Revenue, USD Million, 2013 - 2024) • Hospitals • Blood donation camps • Academic institutions • Others Vein Illuminator Regional Outlook (Revenue, USD Million, 2013 - 2024) • North America • Europe • Asia Pacific • Latin America • MEA Access press release of this research report by Grand View Research: http://www.grandviewresearch.com/press-release/global-vein-illuminator-market About Grand View Research Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare. Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc For more information: www.grandviewresearch.com

Hyaluronic Acid Market Is Likely To Be Influenced By The Increase In Obesity Till 2024: Grand View Research, Inc.

Protein Purification & Isolation Market Is Predicted To Grow Swiftly Due To Increased Research In The Fields Of Biotechnology & Pharmaceuticals Till 2025: Grand View Research, Inc.